drugset / Trial / NCT00006044

Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy

NCT00006044

Treatment

Summary

RATIONALE: High doses of testosterone may be effective in killing prostate cancer cells that no longer respond to hormone therapy. PURPOSE: Phase I trial to study the effectiveness of testosterone in treating patients who have progressive prostate cancer that no longer responds to hormone therapy.

Timeline

Start
2000-02
Primary completion
2005-02
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule Other

Indications